FAST-CLEAR
Live / Registered — Registered (as of 03 Oct 2023)
What this means for you
Registered since 03 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88514430
- Registration number
- 7183144
- Mark type
- Stylized text
- Filed
- 15 Jul 2019
- Published for opposition
- 24 Mar 2020
- Registered
- 03 Oct 2023
- Attorney of record
- Jonathan M. Gelchinsky
Goods and services
- Class 001 — Chemicals: Bifunctional chelate material to be used in drug discovery, pharmaceutical development and clinical research
- Class 005 — Pharmaceuticals: Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to cancer cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use
Owner
- Fusion Pharmaceuticals Inc., Hamilton, Ontario, CA
- Fusion Pharmaceuticals Inc., Hamilton, Ontario, CA
- Fusion Pharmaceuticals Inc., Hamilton, Ontario, CA
Prosecution history
- 03 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 01 Sept 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Aug 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Aug 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Aug 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Aug 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 May 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 May 2023 — NON-FINAL ACTION E-MAILED
- 31 May 2023 — SU - NON-FINAL ACTION - WRITTEN
- 17 May 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 15 May 2023 — USE AMENDMENT FILED
- 15 May 2023 — TEAS STATEMENT OF USE RECEIVED
- 29 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Nov 2022 — SOU EXTENSION 5 GRANTED